Thema
Journal Article
165
Research Support, Non-U.S. Gov't
85
Receptors, Chimeric Antigen
31
Review
30
Immunotherapy
26
Antigens, CD19
21
615
18
che
18
Receptors, Antigen, T-Cell
17
A61P: Specific therapeutic activity of chemical compounds or medicinal preparations
16
C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000)
16
Multicenter Study
16
A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
13
Acute myeloid leukemia
12
CAR T-cell therapy
11
Antibodies, Bispecific
10
Research Support, N.I.H., Extramural
10
Case Reports
9
Chimeric antigen receptor
9
immunotherapy
9
AML
8
Antineoplastic Agents
8
117896-08-9
7
Biomarkers, Tumor
7
Fluorodeoxyglucose F18
7
Nucleophosmin
7
Sialic Acid Binding Ig-like Lectin 3
7
Adoptive T cell therapy
6
Antineoplastic Agents, Immunological
6
Bispecific antibody
6
Cytokines
6
NPM1 protein, human
6
PD-1
6
Programmed Cell Death 1 Receptor
6
4MD2J2T8SJ
5
Acute myeloid leukemia (AML)
5
Adaptor Proteins, Signal Transducing
5
Alemtuzumab
5
Antibodies, Monoclonal
5
Antigens, CD
5
Antigens, Neoplasm
5
Bispecific antibodies
5
CD33 protein, human
5
COVID-19
5
Cancer immunotherapy
5
EC 2.7.10.1
5
Immune checkpoint molecules
5
Letter
5
Lugano criteria
5
Multiple myeloma
5
mehr ...